Endoscopic Findings of Esophagitis in Concurrent Chemo-radiotherapy for Lung Cancer

Hirokazu Watanabe, Saeko Hirota, Toshinori Soejima, Kenya Honda, Koichi Kono, Yoshio Hishikawa, Kayoko Obayasi, Yoshiki Takada

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We performed esophageal endoscopy with concurrent chemo-radiotherapy for lung cancer in 19 patients. Endoscopical examination proved that seven patients (36.8 %) had esophageal erosion or coating (grade 2), four patients (21.1%) had ulcer or bleeding (grade 3) confined to the radiation field, and only one patient (5.3%) had severe symptoms (WHO grade 3). There was a discrepancy between patients' symptoms and endoscopical findings. Endoscopically proven esophagitis, that is, erosion or coating (grade 2), and ulcer or bleeding (grade 3 ), was more frequent in the daily low-dose chemotherapy group (5/5) than in the full dose chemotherapy group (5/14) (p < 0.05). One patient with grade 3 endoscopial damage showed less recovery ; in spite of three months medication. In concurrent radiochemotherapy in which the radiation field includes the esophagus, careful attention should be given to radiation esophagitis, which may be underestimated when asessed on the basis of subjective symptoms alone. Therefore, endoscopy is recommended even if patients have few complaints, and once the esophageal ulcer is proven (grade 3), it should be closely followed up using endoscopy.

Original languageEnglish
Pages (from-to)271-276
Number of pages6
JournalNippon Acta Radiologica
Volume58
Issue number6
Publication statusPublished - 1998
Externally publishedYes

Fingerprint

Esophagitis
Lung Neoplasms
Radiotherapy
Endoscopy
Ulcer
Radiation
Hemorrhage
Drug Therapy
Chemoradiotherapy
Esophagus

Keywords

  • Chemotherapy
  • Esophagttis
  • Lung cancer
  • Radiotherapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Watanabe, H., Hirota, S., Soejima, T., Honda, K., Kono, K., Hishikawa, Y., ... Takada, Y. (1998). Endoscopic Findings of Esophagitis in Concurrent Chemo-radiotherapy for Lung Cancer. Nippon Acta Radiologica, 58(6), 271-276.

Endoscopic Findings of Esophagitis in Concurrent Chemo-radiotherapy for Lung Cancer. / Watanabe, Hirokazu; Hirota, Saeko; Soejima, Toshinori; Honda, Kenya; Kono, Koichi; Hishikawa, Yoshio; Obayasi, Kayoko; Takada, Yoshiki.

In: Nippon Acta Radiologica, Vol. 58, No. 6, 1998, p. 271-276.

Research output: Contribution to journalArticle

Watanabe, H, Hirota, S, Soejima, T, Honda, K, Kono, K, Hishikawa, Y, Obayasi, K & Takada, Y 1998, 'Endoscopic Findings of Esophagitis in Concurrent Chemo-radiotherapy for Lung Cancer', Nippon Acta Radiologica, vol. 58, no. 6, pp. 271-276.
Watanabe H, Hirota S, Soejima T, Honda K, Kono K, Hishikawa Y et al. Endoscopic Findings of Esophagitis in Concurrent Chemo-radiotherapy for Lung Cancer. Nippon Acta Radiologica. 1998;58(6):271-276.
Watanabe, Hirokazu ; Hirota, Saeko ; Soejima, Toshinori ; Honda, Kenya ; Kono, Koichi ; Hishikawa, Yoshio ; Obayasi, Kayoko ; Takada, Yoshiki. / Endoscopic Findings of Esophagitis in Concurrent Chemo-radiotherapy for Lung Cancer. In: Nippon Acta Radiologica. 1998 ; Vol. 58, No. 6. pp. 271-276.
@article{9abb39bbfcef436dacf6172448c7efb9,
title = "Endoscopic Findings of Esophagitis in Concurrent Chemo-radiotherapy for Lung Cancer",
abstract = "We performed esophageal endoscopy with concurrent chemo-radiotherapy for lung cancer in 19 patients. Endoscopical examination proved that seven patients (36.8 {\%}) had esophageal erosion or coating (grade 2), four patients (21.1{\%}) had ulcer or bleeding (grade 3) confined to the radiation field, and only one patient (5.3{\%}) had severe symptoms (WHO grade 3). There was a discrepancy between patients' symptoms and endoscopical findings. Endoscopically proven esophagitis, that is, erosion or coating (grade 2), and ulcer or bleeding (grade 3 ), was more frequent in the daily low-dose chemotherapy group (5/5) than in the full dose chemotherapy group (5/14) (p < 0.05). One patient with grade 3 endoscopial damage showed less recovery ; in spite of three months medication. In concurrent radiochemotherapy in which the radiation field includes the esophagus, careful attention should be given to radiation esophagitis, which may be underestimated when asessed on the basis of subjective symptoms alone. Therefore, endoscopy is recommended even if patients have few complaints, and once the esophageal ulcer is proven (grade 3), it should be closely followed up using endoscopy.",
keywords = "Chemotherapy, Esophagttis, Lung cancer, Radiotherapy",
author = "Hirokazu Watanabe and Saeko Hirota and Toshinori Soejima and Kenya Honda and Koichi Kono and Yoshio Hishikawa and Kayoko Obayasi and Yoshiki Takada",
year = "1998",
language = "English",
volume = "58",
pages = "271--276",
journal = "Nippon Acta Radiologica",
issn = "0048-0428",
publisher = "Japan Radiological Society",
number = "6",

}

TY - JOUR

T1 - Endoscopic Findings of Esophagitis in Concurrent Chemo-radiotherapy for Lung Cancer

AU - Watanabe, Hirokazu

AU - Hirota, Saeko

AU - Soejima, Toshinori

AU - Honda, Kenya

AU - Kono, Koichi

AU - Hishikawa, Yoshio

AU - Obayasi, Kayoko

AU - Takada, Yoshiki

PY - 1998

Y1 - 1998

N2 - We performed esophageal endoscopy with concurrent chemo-radiotherapy for lung cancer in 19 patients. Endoscopical examination proved that seven patients (36.8 %) had esophageal erosion or coating (grade 2), four patients (21.1%) had ulcer or bleeding (grade 3) confined to the radiation field, and only one patient (5.3%) had severe symptoms (WHO grade 3). There was a discrepancy between patients' symptoms and endoscopical findings. Endoscopically proven esophagitis, that is, erosion or coating (grade 2), and ulcer or bleeding (grade 3 ), was more frequent in the daily low-dose chemotherapy group (5/5) than in the full dose chemotherapy group (5/14) (p < 0.05). One patient with grade 3 endoscopial damage showed less recovery ; in spite of three months medication. In concurrent radiochemotherapy in which the radiation field includes the esophagus, careful attention should be given to radiation esophagitis, which may be underestimated when asessed on the basis of subjective symptoms alone. Therefore, endoscopy is recommended even if patients have few complaints, and once the esophageal ulcer is proven (grade 3), it should be closely followed up using endoscopy.

AB - We performed esophageal endoscopy with concurrent chemo-radiotherapy for lung cancer in 19 patients. Endoscopical examination proved that seven patients (36.8 %) had esophageal erosion or coating (grade 2), four patients (21.1%) had ulcer or bleeding (grade 3) confined to the radiation field, and only one patient (5.3%) had severe symptoms (WHO grade 3). There was a discrepancy between patients' symptoms and endoscopical findings. Endoscopically proven esophagitis, that is, erosion or coating (grade 2), and ulcer or bleeding (grade 3 ), was more frequent in the daily low-dose chemotherapy group (5/5) than in the full dose chemotherapy group (5/14) (p < 0.05). One patient with grade 3 endoscopial damage showed less recovery ; in spite of three months medication. In concurrent radiochemotherapy in which the radiation field includes the esophagus, careful attention should be given to radiation esophagitis, which may be underestimated when asessed on the basis of subjective symptoms alone. Therefore, endoscopy is recommended even if patients have few complaints, and once the esophageal ulcer is proven (grade 3), it should be closely followed up using endoscopy.

KW - Chemotherapy

KW - Esophagttis

KW - Lung cancer

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=0032060982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032060982&partnerID=8YFLogxK

M3 - Article

VL - 58

SP - 271

EP - 276

JO - Nippon Acta Radiologica

JF - Nippon Acta Radiologica

SN - 0048-0428

IS - 6

ER -